Protein, pathway design: The Digest’s 2017 Multi-Slide Guide to Arzeda

May 22, 2017 |

Arzeda’s proprietary technology combines targeted computational enzyme design and protein optimization with state-of-the-art metabolic bioengineering to create entirely novel designer cell factories capable of industry-scale chemical production.

CEO Alex Zanghellini gave this illuminating overview of Arzeda’s breakthrough technology at ABLC 2017 in Washington, DC.

Prev1 of 15
Use your ← → (arrow) keys to browse

Print Friendly, PDF & Email


Category: 8-Slide Guide

Thank you for visting the Digest.